US2018273594A1PendingUtilityA1

Treatment of retinitis pigmentosa

Assignee: UNIV OXFORD INNOVATION LTDPriority: Sep 10, 2015Filed: Sep 9, 2016Published: Sep 27, 2018
Est. expirySep 10, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 27/02C12N 2830/008A61K 48/005C12Y 207/11014C07K 14/4702C12N 2800/22C12N 15/86C12N 2750/14171A61K 48/00C12N 2750/14143C12N 9/12
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A polynucleotide comprising a nucleotide sequence encoding the retinitis pigmentosa GTPase regulator ORF15 isoform (RPGR ORF15 ), wherein the RPGR ORF15 -encoding nucleotide sequence has been codon optimised to increase fidelity of replication of the sequence.

Claims

exact text as granted — not AI-modified
1 - 48 . (canceled) 
     
     
         49 . A composition comprising a nucleic acid comprising
 (a) a sequence encoding a rhodopsin kinase promoter, and   (b) a sequence encoding a retinitis pigmentosa GTPase regulator ORF15 isoform (RPGR ORF15 ).   
     
     
         50 . The composition of  claim 49 , wherein the rhodopsin kinase promoter is a GRK1 promoter. 
     
     
         51 . The composition of  claim 49  or  50 , wherein the sequence encoding the promoter has at least 80% identity to the nucleic acid sequence of SEQ ID NO: 7. 
     
     
         52 . The composition of any one of  claims 49  to  51 , wherein the sequence encoding the promoter comprises the nucleic acid sequence of SEQ ID NO: 7. 
     
     
         53 . The composition of any one of  claims 49  to  51 , wherein the sequence encoding the promoter consists of the nucleic acid sequence of SEQ ID NO: 7. 
     
     
         54 . The composition of any one of  claims 49  to  53 , wherein the sequence encoding the RPGR ORF15  is a human RPGR ORF15  sequence. 
     
     
         55 . The composition of any one of  claims 49  to  54 , wherein the sequence encoding the RPGR ORF15  comprises a nucleotide sequence encoding an amino acid sequence that has at least 80% identity to the amino acid sequence of SEQ ID NO: 1. 
     
     
         56 . The composition of any one of  claims 49  to  55 , wherein the sequence encoding the RPGR ORF15  comprises a nucleotide sequence that has at least 80% identity to the nucleic acid sequence of SEQ ID NO: 2. 
     
     
         57 . The composition of  claim 56 , wherein the sequence encoding the RPGR ORF15  comprises a nucleotide sequence that has at least 97% identity to the nucleic acid sequence of SEQ ID NO: 2. 
     
     
         58 . The composition of any one of  claims 49  to  54 , wherein the sequence encoding the RPGR ORF15  comprises a nucleotide sequence that has at least 80% identity to the nucleic acid sequence of SEQ ID NO: 3. 
     
     
         59 . The composition of  claim 58 , wherein the sequence encoding the RPGR ORF15  comprises a nucleotide sequence that has at least 97% identity to the nucleic acid sequence of SEQ ID NO: 3.

Join the waitlist — get patent alerts

Track US2018273594A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.